Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes ...Middle East

NEW YORK, Jan. 11, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today top-line results from its Phase 3 randomized, double-blind, placebo-controlled,...

Hence then, the article about oramed announces top line results from phase 3 trial of ormd 0801 for the treatment of type 2 diabetes was published today ( Thursday 12/01/2023 - 04:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes )

Also on site :

• President Trump Buys DraftKings, Red Rock, Sells Other Gaming Stocks
• Nordstrom Rack Has 'Stylish and 'Supportive' Sandals That You'll Want to Wear 'All Day' on Sale for 50% Off
• Walmart Is Selling a 'Wonderful' Marc Jacobs Tote Bag for $74 Off, and It's the Perfect 'Roomy' Travel Bag